# FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors

> **NCT03451123** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 1 (actual)

## Conditions studied

- Pediatric Brain Tumors

## Interventions

- **DRUG:** FET PET/MRI

## Key facts

- **NCT ID:** NCT03451123
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-23
- **Primary completion:** 2023-08-29
- **Final completion:** 2023-08-29
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451123, "FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03451123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*